QQ客服 官方微博 反馈留言

	Clinical outcome of neoadjuvant chemoradiation therapy with oxaliplatin and capecitabine or 5-fluorouracil for locally advanced rectal cancer
	Lu, Jun-Yang; Xiao, Yi; Qiu, Hui-Zhong; Wu, Bin; Lin, Guo-Le; Xu, Lai; Zhang, Guan-Nan; Hu, Ke
	2013
卷号	108期号:4页码:213-219
关键词	combined modality therapy rectal cancer pathologic response survival
ISSN号	0022-4790
DOI	10.1002/jso.23394
URL标识	查看原文
收录类别	SCIE ; PUBMED
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/6705626
专题	中国医学科学院 北京协和医学院
推荐引用方式 GB/T 7714	Lu, Jun-Yang,Xiao, Yi,Qiu, Hui-Zhong,et al. Clinical outcome of neoadjuvant chemoradiation therapy with oxaliplatin and capecitabine or 5-fluorouracil for locally advanced rectal cancer[J],2013,108(4):213-219.
APA	Lu, Jun-Yang.,Xiao, Yi.,Qiu, Hui-Zhong.,Wu, Bin.,Lin, Guo-Le.,...&Hu, Ke.(2013).Clinical outcome of neoadjuvant chemoradiation therapy with oxaliplatin and capecitabine or 5-fluorouracil for locally advanced rectal cancer.,108(4),213-219.
MLA	Lu, Jun-Yang,et al."Clinical outcome of neoadjuvant chemoradiation therapy with oxaliplatin and capecitabine or 5-fluorouracil for locally advanced rectal cancer".108.4(2013):213-219.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。